REACH

Webpage on revocations launched

Under certain circumstances, companies can permanently or temporarily lose their REACH registration numbers. Registrations may be revoked or otherwise become invalid for different reasons. When this happens, the company is no longer allowed to manufacture or import the substance in the European Economic Area (EEA). 

ECHA also implements sanctions adopted by the Council of the European Union following Russia’s unprovoked military aggression against Ukraine. We will freeze the REACH registrations of companies and individuals listed by the EU sanction legislation.

Testing proposals

We have launched 40 new consultations on testing proposals. Give your comments by 21 July 2023.

There are currently 49 open consultations on testing proposals.

CLP

Intentions to harmonised classification and labelling

One intention has been received for:

• 2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol (EC 689-176-3, CAS 13956-29-1)

Biocides

Commission decision on Union authorisation

The European Commission has granted a Union authorisation for:

• the single biocidal product 'Spray On wipes'
• the single biocidal product 'APESIN alcogel'
• the single biocidal product 'Manorapid express'
• the single biocidal product 'Manorapid express GEL'
• the single biocidal product 'Superficid express WIPES'
• the single biocidal product 'APESIN Spray'
• the single biocidal product 'OP Plus'

Commission decisions on active substances

Commission decisions approving:

• (13Z)-hexadec-13-en-11-yn-1-yl acetate for product-type 19
• ozone generated from oxygen for product-types 2, 4, 5 and 11

Commission decision not approving:

• cyanamide for product-types 3 and 18

Commission decisions postponing the expiry date
of the approval of:

• deltamethrin for product-type 18
• lambda-cyhalothrin for product-type 18
• metofluthrin for product-type 18
• Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52 for product-type 18

Commission decision on product authorisation

Commission decision on the unresolved objections regarding authorisation for:

• biocidal product A-Quasan

ECHA

Scientific article on IUCLID database on pharmaceuticals

ECHA’s scientists have co-authored an article on methodological aspects of developing a non-clinical and clinical IUCLID database for 530 pharmaceuticals. It is published in Regulatory Toxicology and Pharmacology.

EU Chemicals Legislation Finder

Reminder: Data service provider for EUCLEF

We are looking for a contractor to supply regulatory information on how a chemical is regulated at EU level, as well as provide IT solutions and Helpdesk services for the European Union Chemicals Legislation Finder. The deadline for tenders is 21 June 2023.

Board of Appeal

Appeal against a compliance check decision mainly dismissed

Case A-001-2022 concerned an appeal against requests for information on mutagenicity, toxicity testing on fish, and degradation testing concerning the substance 4,4'-(9H-fluoren-9-ylidene)bis(2-chloroaniline).

In reaching its decision, the Board of Appeal was required to give its interpretation on several provisions of the REACH Regulation. Of particular note, the Board of Appeal provided clarity on the applicable version of test guidelines registrants must follow when conducting studies required under REACH to generate information on intrinsic properties of substances.

Other

EFSA call for data: migration and occurrence of plasticisers in food and food contact materials

European Food Safety Authority is looking for data on phthalates, structurally similar substances and replacement substances migrating from or occurring in food contact materials. In addition, data collection on the occurrence of plasticisers in food is also ongoing.

Both calls are open until 31 August 2023. If you intend to submit migration or concentration data, express your interest to data.collection@efsa.europa.eu preferably by 30 June 2023.

OECD: people willing to pay a significant amount to avoid chemicals-related health effects

The OECD has published new willingness-to-pay (WTP) values covering five health effects: infertility, chronic kidney disease, very low birth weight, asthma and IQ loss. According to surveys conducted in 22 countries, people are e.g. willing to pay on average almost 100 000 dollars to avoid infertility and over one million to avoid very low birth weight. 

This OECD project, which ECHA took part in, establishes internationally comparable WTP values to measure the socio-economic benefits of reducing chemical risks. For REACH, these values are important in restrictions and applications for authorisation.

REACH Committee meets in June

The next meeting of the European Commission’s REACH Committee will take place on 21-22 June 2023. The agenda is available online.

Give us feedback

Use our feedback form and tell us what you think of our bulletin.